Article
TNFalpha in patients with end-stage heart failure on medical therapy or supported by a left ventricular assist device.
Transplant immunology - 1 Apr 2008
Bruggink A H, van Oosterhout M F M, De Jonge N, Gmelig-Meyling F H J, De Weger R A
Abstract excerpt
BACKGROUND: In the heart elevated levels of TNFalpha can cause lethal heart failure, like Dilated Cardiomyopathy (DCM). The level of TNFalpha production is in part determined by promoter gene polymorphisms. We investigated whether the TNFalpha promoter gene polymorphism is in this way involved in the outcome of end-stage heart failure and predicts whether patients require left ventricular assist device (LVAD)...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
